Valeant’s tiny forecast boost can’t cover up its issues

WOMP WOMP!
http://www.theglobeandmail.com/globe-investor/investment-ideas/valeants-tiny-forecast-boost-cant-cover-up-its-issues/article34931785/

 

Valeant Pharmaceuticals' Q1 Report Might Be the Greatest Smoke-and-Mirrors Show You'll Ever See
https://www.fool.com/investing/2017/05/10/valeant-pharmaceuticals-q1-report-might-be-the-gre.aspx

 

Agreed. Mostly short covering for those who stupidly shorted at 9-10, thinking this lemon will sink to 0-5. Once the smoke clears, it will start drifting back down again. Fair value is probably around 10, if nothing else changes, and the Q1 results is just a flat whimper with nothing really new to report except they keep spinning it.